Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 07 Jan 2028. The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopaus…
Opportunity overview
- Project name
- Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)?
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 07 Jan 2028. The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopaus…
Who is funding Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)?
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) is funded by National Institutes of Health.
When is the deadline to apply for Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)?
The application deadline is 07 Jan 2028 00:00 (UTC).
Where will the Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) project take place?
The project location(s) are: United States.
How can I apply for Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.